Résultats de la recherche

  • Flux RSS
(1 - 20 of 122)

Pages

Hepatitis C virus co-opts innate immunity component for lipid droplet formation
Overcoming the roadblocks in hepatitis C virus infection
Curing chronic hepatitis C--the arc of a medical triumph
Addressing the Challenges of Hepatitis C Cure and Persistent Risk of Hepatocellular Carcinoma
Viral hepatitis: A new HCV cell culture model for the next clinical challenges
Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges
Boceprevir and personalized medicine in hepatitis C virus infection
Modeling the antiviral activity of ribavirin against hepatitis C virus in cell culture
Mortality from liver cirrhosis and HCC in the DAA era: success in viral control is darkened by raise of metabolic disease
A new HCV mouse model on the block
A first step towards a mouse model for hepatitis C virus infection containing a human immune system
Viral factors and outcome of chronic hepatitis B revisited
Entry inhibitors and future treatment of hepatitis C
A bile acid transporter as a candidate receptor for hepatitis B and D virus entry
Opening the door for hepatitis C virus infection in genetically humanized mice
Triglyceride synthesis and hepatitis C virus production: identification of a novel host factor as antiviral target
Interferon-lambda polymorphisms and hepatitis C virus clearance revisited
Genetically humanized mice recapitulate the entire hepatitis C virus life cycle
Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma
miR-122 - a key factor and therapeutic target in liver disease.

Pages

Islandora displays